ALLINAIRE THERAPEUTICS
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. The technology is based on the discovery by scientific founders Irina Petrache, MD, and Matthias Clauss, Ph.D. of a novel therapeutic target that plays a central role in the development and progression of lung disease.
ALLINAIRE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.allinaire.com
Total Employee:
1+
Status:
Active
Contact:
+1 216-455-3200
Email Addresses:
[email protected]
Total Funding:
1.57 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Typekit
Current Advisors List
Current Employees Featured
Founder
Investors List
BioCrossroads
BioCrossroads investment in Seed Round - Allinaire Therapeutics
IU Ventures
IU Ventures investment in Seed Round - Allinaire Therapeutics
BioMotiv
BioMotiv investment in Seed Round - Allinaire Therapeutics
Official Site Inspections
http://www.allinaire.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Allinaire Therapeutics" on Search Engine
Allinaire Therapeutics - Crunchbase Company Profile
Phone Number +1 216-455-3200. Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary …See details»
Allinaire Therapeutics | LinkedIn
Allinaire Therapeutics | LinkedIn. Biotechnology Research. Beachwood, OH 144 followers. Developing novel therapeutics for cardiopulmonary diseases. View all 4 employees. …See details»
Chiesi Enters Agreement with Allinaire Therapeutic, LLC
Feb 5, 2022 Chiesi Farmaceutici S.p.A. (Chiesi Group), the international research-focused pharmaceutical and healthcare group, announced it has entered into an agreement with …See details»
Allinaire Therapeutics Company Profile - Craft
Allinaire Therapeutics is a company that develops treatments for chronic obstructive pulmonary disease and other pulmonary diseases. It leverages technology based on a …See details»
Allinaire Therapeutics - Funding, Financials, Valuation
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.See details»
Allinaire Therapeutics, a New Biotechnology Start-Up, Launches …
May 2, 2016 Allinaire Therapeutics, a New Biotechnology Start-Up, Launches to Combat Lung Diseases. CLEVELAND AND INDIANAPOLIS – May 2, 2016 – BioMotiv, a drug …See details»
Allinaire Therapeutics - PitchBook
Sep 19, 2017 Allinaire Therapeutics Overview. Update this profile. Year Founded. 2011. Status. Private. Employees. 4. Latest Deal Type. 2ndary - Private. Investors. 5. General …See details»
Advancing Pulmonary Arterial Hypertensions (PAH) Therapeutic
Aug 15, 2023 announced it has entered into an agreement with Allinaire Therapeutic, LLC, a company founded by BioMotiv, to acquire the world-wide rights to a portfolio of …See details»
Leadership Overview — Allinaire Therapeutics
Arthur Bertelsen, PhD Business Advisor and Member of the Board Former VP, Research Collaborations, BMS Schering-Plough Research Institute. Brian Stemme Member of the …See details»
Allinaire Therapeutics - Contacts, Employees, Board Members, …
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.See details»
Allinaire Therapeutics | VentureRadar
Website: http://allinaire.com. Develops novel treatments for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases by targeting a central role in lung …See details»
Chiesi inks pact with Allinaire to acquire therapeutic mAbs against ...
May 3, 2022 Chiesi Farmaceutici S.p.A. (Chiesi Group), the international research-focused pharmaceutical and healthcare group, announced that it has entered into an agreement …See details»
Douglas W.P. Hay, PhD — Allinaire Therapeutics
Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, OH 44106. [email protected] ...See details»
Allinaire Therapeutics - Crunchbase
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.See details»
2022 for Chiesi: The Group’s international growth - GlobeNewswire
Apr 11, 2023 Going into the details of the research projects, the partnership with Allinaire Therapeutics continues on the monoclonal antibody program as a potential treatment of …See details»
BioMotiv | Harrington Discovery Institute at University Hospitals
Allinaire Therapeutics, a BioMotiv portfolio company, is advancing a novel treatment for pulmonary arterial hypertension (PAH). In 2022, the international research-focused …See details»
Irina Petrache, MD — Allinaire Therapeutics
Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, OH 44106. [email protected] ...See details»
Allinaire Therapeutics - Tech Stack, Apps, Patents & Trademarks
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.See details»
Wade Lange - Founder @ Allinaire Therapeutics - Crunchbase
Wade Lange. Summary. Overview. Number of Current Board & Advisor Roles 1. Number of Founded Organizations 1. Primary Job Title Founder. Primary Organization. Allinaire …See details»